Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,867,311,601
+$707,230,896 QoQ
Shares Held
81,020,390
+3.9% QoQ
Ownership
11.2%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1
of 489 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,175,833 across 370 Biotechnology names. ROIV ranks #4 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
This page
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in ROIV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,867,311,601 | 81,020,390 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,160,080,705 | 77,981,253 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,427,414,366 | 65,779,464 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $919,404,466 | 60,766,984 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $625,589,595 | 55,509,281 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $521,315,095 | 51,666,511 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $583,237,726 | 49,301,583 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $567,133,944 | 49,145,056 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $492,045,611 | 46,551,146 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $372,489,533 | 35,340,563 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $415,243,264 | 36,976,248 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $454,476,098 | 38,910,625 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $362,851,109 | 35,997,134 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $227,025,655 | 30,762,284 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $242,668,204 | 30,371,490 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,443,595 | 4,175,030 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $10,175,000 | 2,500,000 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $12,350,000 | 2,500,000 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $25,200,000 | 2,500,000 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||